Time to Conversion to an Everolimus‐Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry
Faouzi Saliba, Sébastien Dharancy, Ephrem Salamé, Filoména Conti, Daniel Eyraud, Sylvie Radenne, Térésa Antonini, Olivier Guillaud, Jean Guguenheim, Martine Neau‐Cransac, Eléonora Demartin, Guillaume Lasailly, Christophe Duvoux, Rodolphe Sobesky, Audrey Coilly, Sylvie Tresson, Valérie Cailliez, Olivier Boillot, Georges Philippe Pageaux, Didier Samuel, Yvon Calmus, Jérôme Dumortier – 31 August 2020 – Longterm use of a calcineurin inhibitor (CNI)–based regimen is one of the major reasons for chronic renal failure in liver transplantation recipients (LTRs).